Painreform is trading 9.25% up at $0.78 after hours, with no verified company-specific announcement or other clear catalyst identified.
- Price compares with the $0.71 regular-session close on November 3, 2026.
- Latest investor-relations releases listed were dated September 2026; the reported October 23 shareholder update does not establish a reason.
- November 3: Nasdaq rose, Dow fell and S&P 500 gain was modest; this does not clearly explain the move. After-hours volume and activity were unverified.